Home/Filings/4/0002001011-25-000125
4//SEC Filing

Espinoza Octavio 4

Accession 0002001011-25-000125

CIK 0000886163other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 6:36 PM ET

Size

4.5 KB

Accession

0002001011-25-000125

Insider Transaction Report

Form 4
Period: 2025-12-12
Espinoza Octavio
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-12-12$188.31/sh1,804$339,71126,186 total

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001905248

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:36 PM ET
Size
4.5 KB